Inflammation News and Research

RSS

Certain regions in the retina are more affected by Alzheimer's disease, shows study

A study led by the Cedars-Sinai Department of Neurosurgery has identified certain regions in the retina - the lining found in the back of the eye - that are more affected by Alzheimer's disease than other areas.

18 Nov 2020

Hydrogen therapy may help severely ill COVID-19 patients

Researchers from the Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu in China, have explored the possibility of using hydrogen therapy on severely ill COVID-19 patients. The team published their study's findings, titled "Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients," in the latest issue of the journal Frontiers in Pharmacology.

17 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Researchers identify anti-inflammatory mechanisms that drive alcohol addiction

Deep within the brain, a small almond-shaped region called the amygdala plays a vital role in how we exhibit emotion, behavior, and motivation.

17 Nov 2020

Novel mechanism enhances the formation of hematopoietic stem cells

Hematopoietic stem cells can replenish all the different cell types of our blood system. For this reason, hematopoietic stem cells are the cells used in many blood diseases when patients need transplantations.

17 Nov 2020

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

Managing the activity of the BCAP protein could help the body repair intestinal tissue from damage caused by inflammation, according to a new study led by experts at Cincinnati Children's.

17 Nov 2020

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Researchers in France have conducted a study showing that people who are asymptomatic following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – elicit a polyfunctional antibody response to the virus.

16 Nov 2020

Parasite infection discovery could help develop treatments for neurological disorders

New research into how a common parasite infection alters human behavior could help development of treatments for schizophrenia and other neurological disorders.

16 Nov 2020

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Short bursts of physical exercise induce changes in the body's levels of metabolites that correlate to, and may help gauge, an individual's cardiometabolic, cardiovascular and long-term health, a study by Massachusetts General Hospital has found.

16 Nov 2020

Corticosteroids can help in survival of elderly patients with severe COVID-19

A new study group based in France have looked at the rates of survival among elderly patients with COVID-19 who were administered with corticosteroids.

16 Nov 2020

Nanobodies: unharnessed potential in COVID-19 treatment

A new study published in the Journal of Biomolecular Structure and Dynamics in October 2020 discusses the use of nanobodies in diagnosing and treating this deadly disease.

16 Nov 2020

Metabolic biomarkers could predict COVID-19 severity

A new study suggests that metabolic biomarkers could possibly predict the severity of COVID-19 in patients.

16 Nov 2020

Care pathways for pregnant women with COVID‐19

A recent review published in the journal Global Challenges in October 2020, sums up what is currently known about the treatment of COVID-19 during pregnancy and offers recommendations for how healthcare professions might better manage pregnant COVID-19 patients in the future.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women who had no major artery blockage, according to late- breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Study sheds new light on the immune system response to COVID-19

A team of immunology experts from research organizations in Belgium and the UK has come together to apply their pioneering research methods to put individuals' COVID-19 responses under the microscope.

16 Nov 2020

Professional drivers regularly exposed to hazardous levels of diesel emissions, study finds

While taxi drivers wearing face masks have become a common sight in our cities, new research shows there’s a longer-standing threat to the health of professional drivers than coronavirus.

16 Nov 2020

Antiviral immune response is suppressed in COVID-19 patients compared to flu patients

Rather than life-threatening hyperinflammation, most adults with moderate-to-severe COVID-19 have a suppressed viral immune response when compared to adults with another viral respiratory infection, influenza. St. Jude Children's Research Hospital and Washington University School of Medicine in St. Louis led research that suggests most COVID-19 patients are not candidates for treatment with steroids such as dexamethasone.

16 Nov 2020

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

Military and law-enforcement personnel repeatedly exposed to low-level blasts have significant brain changes – including an increased level of brain injury and inflammation – compared with a control group, a new study has found.

16 Nov 2020

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden.

16 Nov 2020

Inflammation News and Research

Certain regions in the retina are more affected by Alzheimer's disease, shows study

Hydrogen therapy may help severely ill COVID-19 patients

Lower dairy intake may be beneficial for people with metabolic syndrome

Researchers identify anti-inflammatory mechanisms that drive alcohol addiction

Novel mechanism enhances the formation of hematopoietic stem cells

Targeting BCAP with new drugs could benefit people with inflammatory bowel disease

Asymptomatic individuals mount polyfunctional antibody response to SARS-CoV-2

Parasite infection discovery could help develop treatments for neurological disorders

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Corticosteroids can help in survival of elderly patients with severe COVID-19

Nanobodies: unharnessed potential in COVID-19 treatment

Metabolic biomarkers could predict COVID-19 severity

Care pathways for pregnant women with COVID‐19

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Study sheds new light on the immune system response to COVID-19

Professional drivers regularly exposed to hazardous levels of diesel emissions, study finds

Antiviral immune response is suppressed in COVID-19 patients compared to flu patients

Exposure to low-level blasts affects the brains of military and law-enforcement personnel

Baricitinib drug can reduce mortality in patients with moderate to severe COVID-19

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News